drugset / Trial / NCT04565847

The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls

NCT04565847

Phase 2 Completed 20 enrolled McMaster University
RandomizedCrossoverQuadruple-blindOther

Summary

The study aim is to investigate if changes in osmolarity using mannitol challenge can evoke coughing healthy controls with no evidence of bronchoconstriction (PC20\>16mg/ml or mannitol PD15 \> 635 mg, or \< 10% incremental fall in FEV1 between consecutive mannitol doses) and if salbutamol can affect this. This is a double-blind, placebo-controlled analysis in healthy controls assessing the effects of salbutamol on mannitol induced cough.

Timeline

Start
2020-11-30
Primary completion
2021-12-16
Completion
2021-12-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown 2.5 mg Other

Indications

No indication recorded.